Activation of AKT and nuclear accumulation of wild type TP53 and MDM2 in anal squamous cell carcinoma

Authors

  • Heena Patel,

    1. Colorectal Cancer Genetics, Institute for Cell and Molecular Sciences, Blizard Building, Barts and The London, Queen Mary's School of Medicine and Dentistry, 4 Newark St., Whitechapel E1 2AT, United Kingdom
    Search for more papers by this author
  • Guadalupe Polanco-Echeverry,

    1. Colorectal Cancer Genetics, Institute for Cell and Molecular Sciences, Blizard Building, Barts and The London, Queen Mary's School of Medicine and Dentistry, 4 Newark St., Whitechapel E1 2AT, United Kingdom
    Search for more papers by this author
  • Stefania Segditsas,

    1. Molecular and Population Genetics Laboratory, London Research Institute, Cancer Research UK, London, WC2A 3PX, United Kingdom
    Search for more papers by this author
  • Emmanouil Volikos,

    1. Colorectal Cancer Genetics, Institute for Cell and Molecular Sciences, Blizard Building, Barts and The London, Queen Mary's School of Medicine and Dentistry, 4 Newark St., Whitechapel E1 2AT, United Kingdom
    Search for more papers by this author
  • Amy McCart,

    1. Colorectal Cancer Genetics, Institute for Cell and Molecular Sciences, Blizard Building, Barts and The London, Queen Mary's School of Medicine and Dentistry, 4 Newark St., Whitechapel E1 2AT, United Kingdom
    Search for more papers by this author
  • Cecilia Lai,

    1. Colorectal Cancer Genetics, Institute for Cell and Molecular Sciences, Blizard Building, Barts and The London, Queen Mary's School of Medicine and Dentistry, 4 Newark St., Whitechapel E1 2AT, United Kingdom
    Search for more papers by this author
  • Thomas Guenther,

    1. Academic Department of Pathology, St. Mark's Hospital, Harrow, Middx HA1 3UJ, United Kingdom
    Search for more papers by this author
  • Abed Zaitoun,

    1. Department of Histopathology, University Hospital, Queens Medical Centre, Nottingham NG7 2UH
    Search for more papers by this author
  • Oliver Sieber,

    1. Cancer and Immunogenetics Laboratory, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, United Kingdom
    Search for more papers by this author
  • Mohammed Ilyas,

    1. School of Molecular Medical Sciences, Division of Pathology, Queen's Medical Centre, Nottingham NG7 2UH, United Kingdom
    Search for more papers by this author
  • John Northover,

    1. St. Mark's Hospital, Harrow, Middx HA1 3UJ, United Kingdom
    Search for more papers by this author
  • Andrew Silver

    Corresponding author
    1. Colorectal Cancer Genetics, Institute for Cell and Molecular Sciences, Blizard Building, Barts and The London, Queen Mary's School of Medicine and Dentistry, 4 Newark St., Whitechapel E1 2AT, United Kingdom
    • Colorectal Cancer Genetics Group, Institute of Cell and Molecular Sciences, Blizard Building, Barts and The London, Queen Mary's School of Medicine and Dentistry, 4 Newark St. Whitechapel E1 2AT
    Search for more papers by this author
    • Fax: +0207-882-2200.


Abstract

Human papilloma virus (HPV) infection is considered as an important aetiological factor for anal squamous cell carcinoma (ASCC) but is not sufficient for tumour progression. This carcinoma is poorly understood at the molecular level. Using the largest cohort of cases to date we investigated the molecular mechanisms underlying ASCC development, in particular the roles of TP53, MDM2 and AKT. Viral infection in our cohort occured at high frequency (73%, 94/128) with HPV16 accounting for the majority (86%, 81/94) of infected cases. Only 4% (5/119) of ASCCs showed TP53 (exons 5–8) mutations, but a high frequency (91%, 100/110) of nuclear protein expression of TP53 was observed. There was a significant association (p < 0.001) between nuclear accumulation of TP53 and MDM2 protein although no MDM2 mutations were found, and copy number was normal. Cellular accumulation of phosphorylated-AKT was observed in 66% (82/125) of ASCCs and an association demonstrated between nuclear accumulation of MDM2 and activated AKT (p < 0.001). We observed a high frequency of copy number gain at PIK3CA (47%), and some coding sequence mutations (4%). Amplification of PIK3CA was associated with presence of phosphorylated-AKT (p= 0.008). There was no association between virus infection and TP53 nuclear accumulation (p = 0.5). However, a significant association was found between infection and MDM2 nuclear staining, and between infection and activated AKT (p = 0.04, p = 0.01, respectively). We propose that activation of AKT, possibly through the PI3K-AKT pathway, is an important component of ASCC tumorigenesis that contributes to MDM2 and TP53 accumulation in the nucleus. © 2007 Wiley-Liss, Inc.

Ancillary